Biote (BTMD) Notes Payables (2020 - 2026)

Biote (BTMD) posted quarterly Notes Payables of $100000.0 for Q4 2024, little changed quarter-over-quarter from $100000.0 in Q3 2024.

Analysis

Biote (BTMD) Notes Payables (2020 - 2026) Analysis & Trends

Biote's Notes Payables history runs 3 years deep, the most recent figure standing at $100000.0 for Q4 2024.

In Q4 2024, Notes Payables changed N/A year-over-year to $100000.0; the TTM figure through Dec 2024 stood at $100000.0 (changed N/A YoY), while the FY2024 annual figure was $100000.0, changed N/A from the prior year.
Notes Payables for Q4 2024 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
The five-year high for Notes Payables was $600000.0 in Q1 2024, with the low at $72800.0 in Q1 2022.
The 3-year median for Notes Payables is $100000.0 (2024), against an average of $182550.0.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	90.36 Bn	89.35 Bn	15.19 Bn
2	Tenet Healthcare	22.02 Bn	19.85 Bn	4.45 Bn
3	Encompass Health	12.13 Bn	11.99 Bn	1.34 Bn
4	Davita	11.78 Bn	11.09 Bn	1.16 Bn
5	Universal Health Services	10.09 Bn	9.95 Bn	3.29 Bn
6	Ensign	9.97 Bn	9.65 Bn	306.24 Mn
7	Chemed	6.93 Bn	6.89 Bn	221.47 Mn
8	Pacs	6.81 Bn	6.64 Bn	338.46 Mn
9	Concentra Group Holdings Parent	4.32 Bn	4.16 Bn	192.10 Mn
10	Biote	44.34 Mn	32.82 Mn	28.92 Mn

Historic Data

Download Data